Cited by 1,697Diabetes Management and EducationChronic Disease Management StrategiesPrimary Care and Health Outcomes

Collaborative care for patients with depression and chronic illnesses

Open access
Katon, Wayne J., Lin, Elizabeth H.B., Von Korff, Michael, Ciechanowski, Paul, Ludman, Evette J., Young, Bessie, Peterson, Do, Rutter, Carolyn M. +2 more·2010·New England Journal of Medicine

Abstract

BACKGROUND: Patients with depression and poorly controlled diabetes, coronary heart disease, or both have an increased risk of adverse outcomes and high health care costs. We conducted a study to determine whether coordinated care management of multiple conditions improves disease control in these patients. METHODS: We conducted a single-blind, randomized, controlled trial in 14 primary care clinics in an integrated health care system in Washington State, involving 214 participants with poorly controlled diabetes, coronary heart disease, or both and coexisting depression. Patients were randomly assigned to the usual-care group or to the intervention group, in which a medically supervised nurse, working with each patient's primary care physician, provided guideline-based, collaborative care management, with the goal of controlling risk factors associated with multiple diseases. The primary outcome was based on simultaneous modeling of glycated hemoglobin, low-density lipoprotein (LDL) cholesterol, and systolic blood-pressure levels and Symptom Checklist-20 (SCL-20) depression outcomes at 12 months; this modeling allowed estimation of a single overall treatment effect. RESULTS: As compared with controls, patients in the intervention group had greater overall 12-month improvement across glycated hemoglobin levels (difference, 0.58%), LDL cholesterol levels (difference, 6.9 mg per deciliter [0.2 mmol per liter]), systolic blood pressure (difference, 5.1 mm Hg), and SCL-20 depression scores (difference, 0.40 points) (P<0.001). Patients in the intervention group also were more likely to have one or more adjustments of insulin (P=0.006), antihypertensive medications (P<0.001), and antidepressant medications (P<0.001), and they had better quality of life (P<0.001) and greater satisfaction with care for diabetes, coronary heart disease, or both (P<0.001) and with care for depression (P<0.001). CONCLUSIONS: As compared with usual care, an intervention involving nurses who provided guideline-based, patient-centered management of depression and chronic disease significantly improved control of medical disease and depression. (Funded by the National Institute of Mental Health; ClinicalTrials.gov number, NCT00468676.).

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1056/nejmoa1003955

Cites

35 of 35 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • A 2021 meta-analysis found that continuous positive airway pressure treatment in adults with type 2 diabetes and obstructive sleep apnea significantly improved A1C.

    “However, a 2021 meta-analysis found that in adults with T2D and OSA, treatment with CPAP resulted in significant improvement in A1C.1638”

    From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [1638]

    The Results and Discussion (pages unavailable) report improved glycated hemoglobin with collaborative care for patients with depression and chronic illness, not CPAP treatment. Searches for CPAP, obstructive sleep apnea, and the claimed 2021 meta-analysis found no passage addressing that claim. (LLM, conf=0.78)

    Experimental — accuracy not yet measured
  • Psychological interventions have additional impact on prevention of clinical CHD, especially in patients who achieved behavioural goals.

    “Two recent meta-analyses and two recent RCTs 86,199,343,348 have also shown their additional impact on the prevention of clinical CHD, especially in patients who achieved their behavioural goals.349”
  • Multimodal behavioural interventions can reduce mood symptoms and enhance health-related quality of life, although evidence for a definite beneficial effect on cardiac endpoints is inconclusive.

    “This approach can reduce mood symptoms and enhance health-related quality of life, although evidence for a definite beneficial effect on cardiac endpoints is inconclusive.”
  • Drugs targeting glutamatergic, GABAergic, opioidergic, and inflammatory systems have been developed and trialled, with promising results for some; however, initial results for many novel treatments have not been replicated.

    “Drugs that focus on the glutamatergic system (ketamine, esketamine, rapastinel), the GABAergic system (brexanolone, SAGE-217), the opioidergic system (buprenorphine, samidorphan), and the inflammatory system (minocycline) have been developed and trialled, with promising results for some. 543-545 However, the initial results for many novel treatments have not been replicated.”
  • The TeamCare trial evaluated a collaborative integrated care model for patients with diabetes and/or heart disease and depression in community-based primary care clinics in Washington State and demonstrated improved physical and mental health outcomes compared to care as usual.

    “such as the TeamCare trial which evaluated a collaborative integrated care model for patients with diabetes and/or heart disease and depression in community-based primary care clinics in Washington State and demonstrated improved physical and mental health outcomes when compared to care as usual 30-32 33”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. [35]Institute of Medicine Crossing the quality chasm: a new health system for the 21st century Washington, DC National Academies Press 2001 25057539

Cited by

Sorted by citations

Authors
Katon, W. J., Lin, E. H. B., Von Korff, M., Ciechanowski, P., Ludman, E. J., Young, B., Peterson, D., Rutter, C. M., McGregor, M., & McCulloch, D.
Affiliations
  • University of Washington (US)
  • Kaiser Permanente Washington Health Research Institute (US)
Venue
New England Journal of Medicine
Published
2010-12-30
Volume
363
Issue
27
Pages
2611-2620
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
OpenAlex
W2153327521
Cited by
1,697
References
35
Citations by year
2026: 52 · 2025: 62 · 2024: 75 · 2023: 79 · 2022: 93 · 2021: 93 · 2020: 124 · 2019: 104 · 2018: 123 · 2017: 124 · 2016: 131 · 2015: 147 · 2014: 152 · 2013: 140 · 2012: 134
FWCI
80.61
Type
journal article
Language
en
Open access
Locations
  • New England Journal of Medicine (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
National Institute of Mental Health (R01MH041739, K08MH069741, MH069741, MH041739)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
  • Health Sciences › Medicine › Epidemiology › Chronic Disease Management Strategies
  • Health Sciences › Health Professions › General Health Professions › Primary Care and Health Outcomes
Keywords
collaborative care, depression, chronic disease, diabetes mellitus, coronary artery disease, HbA1c, LDL cholesterol, blood pressure control, antidepressants, insulin dose adjustment, quality of life, patient satisfaction, integrated care, primary care
MeSH terms
Antidepressive Agents, Antihypertensive Agents, Blood Pressure, Chronic Disease, Cooperative Behavior, Coronary Disease, Depressive Disorder, Major, Major Depressive Disorder, Diabetes Mellitus, Glycated Hemoglobin, Humans, Cholesterol, LDL, Patient Care Team, Primary Health Care, Risk Factors, Single-Blind Method, Patient-Centered Care

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review